Immune Thrombocytopenic Purpura

Common Name(s)

Immune Thrombocytopenic Purpura

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune Thrombocytopenic Purpura" for support, advocacy or research.

APS Foundation of America, Inc.

The APS Foundation of America, Inc. is dedicated to fostering and facilitating joint efforts in the areas of education, public awareness, research and patient services in an effective and ethical manner.

Last Updated: 12 Aug 2013

View Details
Logo
Platelet Disorder Support Association

Our mission is to enhance the lives of patients with immune thrombocytopenic purpura and other platelet disorders.

Last Updated: 24 Nov 2009

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Immune Thrombocytopenic Purpura" for support, advocacy or research.

APS Foundation of America, Inc.

The APS Foundation of America, Inc. is dedicated to fostering and facilitating joint efforts in the areas of education, public awareness, research and patient services in an effective and ethical manner.

http://www.apsfa.org

Last Updated: 12 Aug 2013

View Details
Logo
Platelet Disorder Support Association

Our mission is to enhance the lives of patients with immune thrombocytopenic purpura and other platelet disorders.

http://www.pdsa.org

Last Updated: 24 Nov 2009

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

General Resources

APS Foundation of America, Inc Fan Page

The APS Foundation of America, Inc. is the leading United States nonprofit health agency dedicated to bringing national awareness to Antiphospholipid Antibody Syndrome (APS).

Updated 13 Nov 2012

Go To URL
 
 
Top

Blogs

APS Friends & Support Forum

Are you looking for Support for Antiphospholipid Antibody Syndrome, APS, APLS, APLA, Hughes Syndrome, or Sticky Blood? Well you've come to the right place! This is an private forum for people who have Antiphospholipid Antibody Syndrome, friends, fam

Updated 13 Nov 2012

Go To URL
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Immune Thrombocytopenic Purpura" returned 172 free, full-text research articles on human participants. First 3 results:

Coronary intervention for acute coronary syndrome in a 51-year-old man with immune thrombocytopenic purpura: a case report.
 

Author(s): Bora Demircelik, Meltem Altinsoy, Fadime Bozduman, Mahmut Gunes, Muzaffer Cakmak, Beyhan Eryonucu

Journal:

 

Treatment of the rare cases of patients with chronic idiopathic thrombocytopenic purpura with acute coronary syndrome can be a significant problem. The patient in our case report was treated successfully with percutaneous coronary intervention.

Last Updated: 2 Jul 2014

Go To URL
Immune thrombocytopenic purpura in a liver transplant patient.
 

Author(s): Aysel Ünlüsoy Aksu, Ödül Eğritaş Gürkan, Sinan Sarı, İdil Yenicesu, Buket Dalgıç

Journal: Exp Clin Transplant. 2014 Mar;12 Suppl 1():175-7.

 

Thrombocytopenia is common during the early posttransplant period. Most cases are mild and recover in 1 month. Occasionally, severe thrombocytopenia may occur in the late posttransplant period. We report a 10-year-old boy with severe thrombocytopenia 3.5 years after liver transplant. ...

Last Updated: 18 Mar 2014

Go To URL
Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management.
 

Author(s): Ghassan Zaid, Sharif Dawod, Uri Rosenschein

Journal: Isr. Med. Assoc. J.. 2013 Dec;15(12):775-6.

 

Last Updated: 23 Jan 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Immune Thrombocytopenic Purpura" returned 16 free, full-text review articles on human participants. First 3 results:

Vaccine administration and the development of immune thrombocytopenic purpura in children.
 

Author(s): Valerio Cecinati, Nicola Principi, Letizia Brescia, Paola Giordano, Susanna Esposito

Journal: Hum Vaccin Immunother. 2013 May;9(5):1158-62.

 

The most important reasons cited by the opponents of vaccines are concerns about vaccine safety. Unlike issues such as autism for which no indisputable documentation of direct relationship with vaccine use is available, immune thrombocytopenic purpura (ITP) is an adverse event that ...

Last Updated: 7 Oct 2013

Go To URL
Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions.
 

Author(s): P Anoop

Journal: Indian Pediatr. 2012 Oct;49(10):811-8.

 

Immune thrombocytopenic purpura (ITP) has witnessed many changes and updates over the past decade. The definitions of disease subtypes, course and response to treatment have all been standardized recently. Consequent to the lack of an international consensus management guideline, ...

Last Updated: 12 Nov 2012

Go To URL
The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.
 

Author(s): Maria Nieto, Gonzalo Calvo, Ian Hudson, Peter Feldschreiber, David Brown, Ching Cheng Lee, Geoffrey Lay, Anna Valeri, Eric Abadie, Angela Thomas, Francesco Pignatti

Journal: Haematologica. 2011 Sep;96(9):e33-40.

 

On 11(th) March 2010, the European Commission issued a marketing authorization valid throughout the European Union for Revolade for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura. Revolade is an orphan medicinal product indicated for splenectomized patients ...

Last Updated: 1 Sep 2011

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)
 

Status: Recruiting

Condition Summary: Immune Thrombocytopenic Purpura

 

Last Updated: 15 Dec 2014

Go to URL
MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP
 

Status: Not yet recruiting

Condition Summary: Immune Thrombocytopenic Purpura; Idiopathic Thrombocytopenic Purpura

 

Last Updated: 5 Aug 2014

Go to URL
Helicobacter Pylori Immune Thrombocytopenic Purpura
 

Status: Recruiting

Condition Summary: Immune Thrombocytopenic Purpura

 

Last Updated: 6 Dec 2010

Go to URL